April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Laser peripheral iridotomy versus trabeculectomy as an initial treatment for primary angle-closure glaucoma: a non-randomized comparative study
Author Affiliations & Notes
  • Yuanbo Liang Liang
    Glaucoma, School of Optometry and Eye Hospital, Wenzhou, Wenzhou, China
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • Yanyun Chen
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • Sujie Fan
    Glaucoma, Handan Eye Hospital, Handan, China
  • Hailiin Meng
    Glaucoma, Anyang Eye Hospital, Anyang, China
  • Xing Wang
    Glaucoma, Fushun Eye Hospital, Fushun, China
  • Ravi Thomas
    Glaucoma, Queensland Eye Institute, Queensland, QLD, Australia
  • Shi Song Rong
    OVS, The Chinese University of Hong Kong, Hongkong, China
  • Ningli Wang
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • Footnotes
    Commercial Relationships Yuanbo Liang Liang, None; Yanyun Chen, None; Sujie Fan, None; Hailiin Meng, None; Xing Wang, None; Ravi Thomas, None; Shi Song Rong, None; Ningli Wang, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6123. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuanbo Liang Liang, Yanyun Chen, Sujie Fan, Hailiin Meng, Xing Wang, Ravi Thomas, Shi Song Rong, Ningli Wang; Laser peripheral iridotomy versus trabeculectomy as an initial treatment for primary angle-closure glaucoma: a non-randomized comparative study. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6123.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare the efficacy of laser peripheral iridotomy (LPI) versus trabeculectomy as an initial treatment for primary angle-closure glaucoma (PACG) in China.

Methods: a non-randomized comparative study. 165 patients with PACG, who had participated in two randomized studies from 2006 to2008 and followed-up for a minimum of 12 months, were included.77 eyes from 54 PACG patients who were initially treated with LPI were divided into two groups: group 1 comprised 23 eyes with peripheral anterior synechia (PAS) < 6 clock hours and group 2 included 54 eyes with PAS ≥ 6 clock hours. 111 PACG patients with PAS≥ 6 clock hours who had undergone primary trabeculectomy during the course of another trial formed group 3.

Results: IOP at each visit was significantly lower in group 3 than in groups 1 and group2 (p< 0.001). Mean IOP during follow-up in group 3 (14.0±3.1mmHg) was significantly lower than in group 1 (17.0±3.2mmHg,p< 0.001) and group 2 (22.3±7.5mmHg,p< 0.001). Long-term IOP fluctuation (defined as maximum minus minimum IOP) in group2 (10.7±9.1mmHg) was larger than that in group3 (6.6±3.8mmHg,p< 0.001) and group 1 (6.3±4.6mmHg,p< 0.001). Eight of 23 (34.8%, CI:14.3%-54.2%) eyes in group 1 and 23 of 54 (42.6%, CI: 29.4%-55.8%) eyes in group 2 required a mean of 1.3 and 1.8 IOP lowering medications, respectively, compared to seven of 111 (6.3%, CI: 1.8%-10.8%) of eyes in group 3 needing a mean of 1.1 medications. Six eyes (7.8%, CI:2%-14%)with a baseline PAS ≥ 6 clock hours that underwent initial LPI required a trabeculectomy. 19 eyes in Group 3 developed transient shallow anterior chamberand 16 eyes experienced transient hypotony.13eyes with shallow anterior chamber developed hypotony. Two lines or more of vision loss were observed in18% of the patients in group 3, and 13.0% in the LPI group. Progression of cataract as determined clinically using LOCS charts occurred in one eye (4.3%, CI:-4.0%-12.6%) in group 1, two eyes (3.7%,CI: -1.3%-8.7%) in group 2, and16 eyes (14.4%,CI: 7.9%-20.9%) in group 3.

Conclusions: Primary trabeculectomyis more effective than LPI in lowering IOP and controlling long-term IOP fluctuation in PACG.In developing countries such as hina,trabeculectomymay need to be considered a primary option for PACG with PAS ≥ 6 clock hours.

Keywords: 462 clinical (human) or epidemiologic studies: outcomes/complications • 735 trabecular meshwork • 578 laser  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×